Bull Rankings model

Cognex Corporation (CGNX) stock analysis

Scientific & Technical Instruments. Scored on the same transparent model behind the daily rankings.

Robotics & Automation
★
CGNX
Cognex Corporation · Scientific & Technical Instruments
47.3Score
$62.92Oct 9 close$10.6B
1Y Target$79.11Analyst consensus · 19 analysts
5Y Target$115.82Compound horizon
10Y Target$171.81Long-dated conviction
FCF$268mTTM · 06/26
C
FCF $268m — modest; watch for margin expansion · Trailing twelve months to 06/26 (operating cash flow − capex).
Rev+8.7%FY YoY
B
Revenue +8.7% — at or above S&P median · Computed from the last two annual revenue figures (FY YoY).
D/E0.04
A-
D/E 0.04 — less debt than most Technology peers (≈25th pctile)
P/E60.5x
C
P/E 60.5 — expensive vs Technology peers (≈90th pctile)
PEG2.71
C
PEG 2.71 — expensive relative to growth rate

Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology

Quality-growth score · 47.3
Quality72.6
Growth71.2
Value20.5
Why this score
  • Raising its dividend
Entry · Margin of safety
52-week rangeNear 52-week high
14% off the 12-month high
vs DCF fair value229% aboveest. fair value ~$19
What the price assumes: free cash flow growing about 39% next year, slowing to 4% a year by year ten — vs a starting rate of ~9% our model takes as the middle of three readings — analyst estimates, last year's revenue growth, and the company's own multi-year record.

Model-generatedWritten from the fundamentals then; figures in the text are as of that day, today's are above · Editorial standards

Why now
Cognex's specialized machine vision solutions, particularly its VisionPro software and integrated vision systems, are critical for automating complex manufacturing and distribution processes across diverse industries like mobile phones and e-commerce. This drives robust top-line expansion, as evidenced by 17.1% revenue growth, translating into a healthy 16.1% profit margin and strong free cash flow of $268m. Our model's `Growth` pillar score of 79 underscores this potential, ensuring persistent growth as automation demand compounds.
Moat
Cognex's competitive edge stems from its proprietary VisionPro software, which includes patented vision tools for both traditional rule-based and deep learning-enabled applications. This specialized intellectual property creates significant switching costs for manufacturers and distributors who rely on these systems to automate critical tasks like inspecting automotive components or sorting e-commerce packages, making it difficult for competitors to replicate their integrated solutions.
Risk
The primary concern for Cognex is its stretched valuation, reflected in a P/E of 61.8 and our model's weakest pillar, `Value`, scoring only 21. Our reverse DCF analysis suggests the current price of $64.22 implies an unsustainable ~39%/yr free-cash-flow growth for the next decade, significantly outpacing its current 17.1% revenue growth. A sustained deceleration in demand for machine vision products, particularly from key end markets like mobile phones or automotive components, would quickly expose this premium and confirm the bear case.
Horizon
1-3 yr $79.11 (19-analyst consensus) — fundamentals + valuation re-rating. 5 yr $115.82 at ~13% CAGR — compounding case rests on the competitive position widening. 10 yr $171.81 if current growth sustains into durable earnings power.

CGNX vs the Top Picks average

PillarCGNXBook avgDiff
Quality7383-10
Growth7189-18
Value2076-56

Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.

Trend
+4.8 over 82 daily scores
From 42.5 (Jun 22) → 47.3 (now)

One point per daily run; read From → To for the actual range.

CGNX at a glance

THE BULL RANKINGS SCORECARD47.3/ 100 · BULL SCOREPEER MEDIANQUALITY72.6GROWTH71.2VALUE20.5Reverse-DCF · Price implies ~39% growth a year from here.
PRICE vs OUR DCF FAIR VALUE$18–$20.8FAIR-VALUE RANGE$62.9PRICEOur DCF fair value ~$19.1 · price $62.9 is 229% above it.
ONE-YEAR MOVE VS ITS BETAFLATThis stock+49%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.
PRICE IN ITS 52-WEEK RANGE$62.9LOW $34.6HIGH $72.9Trading at the 74th percentile of its 52-week range ($34.6–$72.9).

Same audited fundamentals as the score, unless a card says otherwise.

Analyst estimate revisions

30-day change+0.2%
90-day change+14.2%
Forward EPS estimate$2.03

Over the last 90 days, what analysts expect CGNX to earn is materially higher (+14.2%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →

Shares to buy
31
Position size
$1,951
3.9% of portfolio
Stop price
$47.19
25% below $62.92
$ at risk if stopped
$487.63
budget $500.00 · 1% of portfolio

Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.

The Bull Rankings deep dive

Analysis as of · figures are as written that day and are not updated. Today's numbers are in the cards above.

Written by the Bull Rankings model from fundamentals as of , and checked against those figures. How we source & verify every figure →

The Bull Rankings scorecard — our quality-growth score is 52.7 / 100, built from three pillars scored 0–100: Quality 73, Growth 79, Value 25 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 37% a year next year, fading to 3% a year by year ten — a gauge of how much optimism is already in the stock.

THE BULL RANKINGS SCORECARD52.7/ 100 · BULL SCOREPEER MEDIANQUALITY73.2GROWTH79.3VALUE25.2Reverse-DCF · Price implies ~37% growth a year from here.

The thesis

The market has priced CGNX like a high-growth compounder, and the numbers back it up—if you believe the growth can last. Revenue grew 17.1% in the year ended 2026-07-05, while profit margins sat at 16.1% and return on equity at 10.7%. Our model flags the weakest pillar as Value, with a score of just 25, but the Growth pillar at 79 is the engine driving the case. The stock’s 57.5 P/E isn’t cheap, but it’s not absurd if the top line keeps expanding at double digits. The real question is whether the market has already baked in too much optimism. The reverse DCF read implies 37% annual free-cash-flow growth (in year one, slowing to 3% a year by year ten)—a figure that towers over the 17.1% revenue growth in the latest year. That gap alone tells you the price assumes more than just steady execution; it assumes acceleration the business hasn’t yet delivered.

What the business actually is

REVENUE TO CASHRevenue$1.1b · 100%Net income$174.8m · 16.1%Free cash flow$268.3m · 24.6%Cash flow exceeds reported profit — high-quality earnings.

Cognex sells machine vision systems that act as the eyes and brains for factories and distribution centers. Its VisionPro software suite—packaged with patented rule-based tools and deep-learning-enabled modules—powers the inspection, measurement, and guidance tasks that keep assembly lines humming. The company’s bread-and-butter are smart cameras and integrated vision systems, sold to manufacturers of discrete goods like mobile phones, automotive parts, and e-commerce packages. When a robot needs to locate a component or a conveyor belt needs to verify a package’s label, Cognex’s stack is often the tool of choice. The durability of this model hinges on the stickiness of its software and the switching costs embedded in industrial workflows.

Why it can (or can't) keep compounding

The moat is software, not hardware. VisionPro’s toolkit is proprietary, and the deep-learning modules are trained on decades of industrial data—data that competitors can’t replicate overnight. The model’s signal that the company is raising its dividend suggests capital discipline, but the real tailwind is the 17.1% revenue growth in the year ended 2026-07-05, a strong pace for an industrial technology business. Margins held at 16.1%, proving the business can scale without fattening costs, while ROE of 10.7% lands in the respectable range for a growth outfit. The risk isn’t execution; it’s saturation. If the next wave of automation demand stalls, the growth pillar could wobble. For now, though, the system is still capturing share in factories and warehouses where precision matters more than price.

The valuation question

PRICE vs OUR DCF FAIR VALUE$19.5$31.6FAIR-VALUE RANGE$59.8PRICEOur DCF fair value ~$23.9 · price $59.8 is 60% above it.

The P/E of 57.5 is steep, but the market isn’t paying for last quarter’s growth alone. The reverse DCF read says today’s price embeds 37% annual free-cash-flow growth (in year one, slowing to 3% a year by year ten), a figure that dwarfs the 17.1% revenue growth in the latest year. That’s the tell: the valuation assumes the company can sustain a pace it hasn’t yet shown. The 1.85 mean analyst recommendation and $80.05 target imply room to run, but the weak Value pillar (25) in our model warns that upside is already priced in. The stock’s year-to-date gain of 80.3% only underscores the point. The market has decided this growth is durable, and it’s willing to pay up for it. The question is whether the bet is on execution or on a miracle.

The bear case

The weakest pillar in our model is Value, and the numbers explain why. The PEG ratio sits at 2.71, a figure that only makes sense if growth accelerates from here. The debt-to-equity ratio of 0.04 is pristine, but that’s cold comfort when the P/E is 57.5 and the reverse DCF implies 37% free-cash-flow growth. The stock’s 85% surge this year suggests the market has already priced in a best-case scenario, leaving little room for error. If revenue growth slips below 10% or margins compress even slightly, the valuation gap between price and fundamentals widens fast.

What would change our mind

BULL SCORE OVER TIME52.7Jun 22Aug 25Ranged 39–55 over 48 trading days · now 52.7 (up +10.2).

First, if revenue growth dips below 15% in a reported quarter, the Growth pillar would start to crack. Second, if the P/E compresses toward 40 while growth holds steady, the Value pillar would improve enough to shift the balance. Finally, if the company signals a slowdown in bookings or guidance, the durability story would lose its shine. Until one of those happens, the market’s bet on CGNX remains intact—but fragile.

Cognex Corporation (CGNX): score, valuation & FAQ

Cognex Corporation (CGNX) is a Scientific & Technical Instruments company that scores 47.3 out of 100 on the Bull Rankings quality-growth model — a below-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are D/E (A-). On valuation, CGNX sits about 229% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 39% next year, slowing to 4% a year by year ten.

Is CGNX a good stock to buy?

Bull Rankings scores CGNX 47.3 out of 100 on its quality-growth model, which is a below-average reading. That is driven by D/E (A-). A score is a quantitative screen of Cognex Corporation's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does CGNX score 47.3 on Bull Rankings?

The score leans on quality at 72.6 out of 100, with value the weakest pillar at 20.5 — the three combine geometrically, so a weak one cannot be papered over by a strong one. CGNX earns its highest marks on D/E (A-). Each signal is graded against sector-aware thresholds rather than one absolute bar, so CGNX is measured against Scientific & Technical Instruments peers, not against the market as a whole.

Is CGNX overvalued or undervalued?

Based on $62.92, CGNX sits about 229% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 39% next year, slowing to 4% a year by year ten. It trades at a 60.5x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in CGNX?

The primary concern for Cognex is its stretched valuation, reflected in a P/E of 61.8 and our model's weakest pillar, `Value`, scoring only 21. Our reverse DCF analysis suggests the current price of $64.22 implies an unsustainable ~39%/yr free-cash-flow growth for the next decade, significantly outpacing its current 17.1% revenue growth. A sustained deceleration in demand for machine vision products, particularly from key end markets like mobile phones or automotive components, would quickly expose this premium and confirm the bear case.

New to these metrics? See the guides and the methodology.

More Test & Measurement stocks by score

All Technology rankings →

Analyze another ticker →